Pictet Asset Management Holding SA boosted its position in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 243.0% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 251,833 shares of the biotechnology company’s stock after buying an additional 178,415 shares [...]